Up-regulated genes in PC2 include CSF1, CSF2RB, CD38, CD36, and FCGR2A, and down-regulated genes include CD34 and CD79B, suggesting that CML HSCs are phenotypically more differentiated towards the myeloid lineage than normal counterparts. Here, CD34 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.